Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 17463
Country/Region: Eswatini
Year: 2017
Main Partner: Columbia University
Main Partner Program: International Center for AIDS Care and Treatment Programs
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $3,886,818 Additional Pipeline Funding: $800,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,118,712
Care: TB/HIV (HVTB) $342,149
Care: Pediatric Care and Support (PDCS) $217,269
Health Systems Strengthening (OHSS) $44,957
Testing: HIV Testing and Counseling (HVCT) $633,042
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $99,731
Treatment: Adult Treatment (HTXS) $1,339,233
Treatment: Pediatric Treatment (PDTX) $91,725
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2018 4
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2018 18
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2018 2
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2018 5
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2018 20
GEND_GBV 15-19, Male, Physical and/or Emotional Violence 2018 7
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2018 17
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2018 17
GEND_GBV 20-24, Male, Physical and/or Emotional Violence 2018 1
GEND_GBV 20-24, Male, Physical and/or Emotional Violence 2018 18
GEND_GBV 25-49, Female, Physical and/or Emotional Violence 2018 5
GEND_GBV 25-49, Female, Physical and/or Emotional Violence 2018 16
GEND_GBV 25-49, Female, Sexual Violence (Post-Rape Care) 2018 15
GEND_GBV 25-49, Male, Physical and/or Emotional Violence 2018 6
GEND_GBV 25-49, Male, Physical and/or Emotional Violence 2018 60
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 74
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 12
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 125
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 74
GEND_GBV Number of people receiving post-GBV care 2018 12
GEND_GBV Number of people receiving post-GBV care 2018 199
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 1,005
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 71,710
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2018 3
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2018 216
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 7
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 629
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 9
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 938
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 49
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 4,532
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2018 122
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 6
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 307
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 91
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 6
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 290
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 7
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 446
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 7
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 364
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 1
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 108
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 13
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 883
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 22
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 1,460
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 61
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 4,198
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 14
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 965
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 27
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 1,787
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2018 263
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 276
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 11
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 19
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 57
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 33
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 15
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 67
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 193
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 227
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 126
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 157
HTS_TST Service Delivery Point (Facility) Other PITC: <1, Negative 2018 6
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 14
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 916
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 3
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 264
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 15
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 896
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 17
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 1,355
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 24
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 1,100
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 3
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 323
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 44
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 2,691
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 52
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 4,476
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 217
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 12,819
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 34
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 2,964
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 99
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 5,463
HTS_TST Service Delivery Point (Facility) TB: <1, Negative 2018 6
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2018 24
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2018 6
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2018 20
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 34
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2018 29
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 8
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 70
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 123
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 332
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 79
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 149
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2018 127
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2018 2
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2018 306
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2018 1
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2018 85
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2018 3
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2018 296
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2018 5
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2018 451
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2018 4
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2018 365
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2018 1
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2018 105
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2018 11
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2018 896
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Female, Negative 2018 17
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Female, Negative 2018 1,490
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Male, Negative 2018 52
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Male, Negative 2018 4,273
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2018 11
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2018 981
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2018 22
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2018 1,802
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2018 365
HTS_TST Sum of Test Result disaggregates 2018 116
HTS_TST Sum of Test Result disaggregates 2018 7,239
HTS_TST_POS By Test Result: Positive 2018 116
HTS_TST_POS By Test Result: Positive 2018 7,239
HTS_TST_POS Service Delivery Point (Facility) ANC: 10-14, Positive 2018 33
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 87
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 295
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 15
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 827
HTS_TST_POS Service Delivery Point (Facility) Index: <1, Positive 2018 28
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2018 75
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2018 21
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2018 82
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 120
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 97
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 25
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 251
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 9
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 418
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 30
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 1,202
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 262
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2018 508
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 12
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 21
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 67
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2018 14
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 25
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 22
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 48
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 218
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 38
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 28
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 87
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 103
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 13
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 248
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 56
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 171
HTS_TST_POS Service Delivery Point (Facility) TB: <1, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Male, Positive 2018 11
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2018 13
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 23
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 73
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2018 14
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2018 28
HTS_TST_POS Service Delivery Point (Facility) VCT: <1, Positive 2018 12
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2018 38
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2018 40
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2018 58
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2018 47
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2018 14
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2018 124
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Female, Positive 2018 208
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Male, Positive 2018 596
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2018 135
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2018 251
PMTCT_ART Already on ART at beginning of current pregnancy 2018 30
PMTCT_ART Already on ART at beginning of current pregnancy 2018 2,347
PMTCT_ART New on ART 2018 13
PMTCT_ART New on ART 2018 1,142
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 43
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 3,489
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 122
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 10,583
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 3,489
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 43
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 2
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 139
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 2,898
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 36
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 10
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 98
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 1
PMTCT_EID Unknown, <= 2 months 2018 340
PMTCT_EID Unknown, <= 2 months 2018 4
PMTCT_EID Unknown, 2 - 12 months 2018 4
PMTCT_STAT By Age (Numerator): : 15-19 2018 18
PMTCT_STAT By Age (Numerator): 10-14 2018 14
PMTCT_STAT By Age (Numerator): 15-19 2018 1,494
PMTCT_STAT By Age (Numerator): 20-24 2018 30
PMTCT_STAT By Age (Numerator): 20-24 2018 2,467
PMTCT_STAT By Age (Numerator): 25-49 2018 74
PMTCT_STAT By Age (Numerator): 25-49 2018 5,996
PMTCT_STAT By known positives: 20-24 2018 4
PMTCT_STAT By known positives: 25-49 2018 16
PMTCT_STAT By new negatives: 15-19 2018 15
PMTCT_STAT By new negatives: 20-24 2018 20
PMTCT_STAT By new negatives: 25-49 2018 43
PMTCT_STAT By new positives: 15-19 2018 3
PMTCT_STAT By new positives: 20-24 2018 6
PMTCT_STAT By new positives: 25-49 2018 15
PMTCT_STAT By Number of known positives: 15-19 2018 47
PMTCT_STAT By Number of known positives: 20-24 2018 421
PMTCT_STAT By Number of known positives: 25-49 2018 1,821
PMTCT_STAT By Number of new negative: 10-14 2018 14
PMTCT_STAT By Number of new negative: 15-19 2018 1,302
PMTCT_STAT By Number of new negative: 20-24 2018 1,731
PMTCT_STAT By Number of new negative: 25-49 2018 3,398
PMTCT_STAT By Number of new positives: 10-14 2018 6
PMTCT_STAT By Number of new positives: 15-19 2018 154
PMTCT_STAT By Number of new positives: 20-24 2018 339
PMTCT_STAT By Number of new positives: 25-49 2018 738
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 10,583
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 122
PMTCT_STAT_den By Age (Denominator): <15-19 2018 1,485
PMTCT_STAT_den By Age (Denominator): 10-14 2018 13
PMTCT_STAT_den By Age (Denominator): 15-19 2018 17
PMTCT_STAT_den By Age (Denominator): 20-24 2018 2,421
PMTCT_STAT_den By Age (Denominator): 20-24 2018 29
PMTCT_STAT_den By Age (Denominator): 25-49 2018 6,590
PMTCT_STAT_den By Age (Denominator): 25-49 2018 77
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 40
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 968
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 13
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 170
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 1,191
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 1,191
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 40
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 968
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 13
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 170
TB_PREV By Age/Sex (Numerator): <15, Female 2018 2
TB_PREV By Age/Sex (Numerator): <15, Female 2018 555
TB_PREV By Age/Sex (Numerator): <15, Male 2018 65
TB_PREV By Age/Sex (Numerator): <15, Male 2018 524
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 77
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 9,647
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 346
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 6,017
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 490
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 16,743
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 490
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 16,743
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 613
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 20,931
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 2
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 694
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 81
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 653
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 97
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 12,063
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 433
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 7,521
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 613
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 20,931
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 63
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,375
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 20
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 243
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 1,701
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 1,736
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 63
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,406
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 20
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 247
TX_CURR Age/Sex: <1 2018 28
TX_CURR Age/Sex: <1 2018 166
TX_CURR Age/Sex: <1-9 2018 1,652
TX_CURR Age/Sex: 1-9 2018 88
TX_CURR Age/Sex: 10-14 Female 2018 2
TX_CURR Age/Sex: 10-14 Female 2018 645
TX_CURR Age/Sex: 10-14 Male 2018 147
TX_CURR Age/Sex: 10-14 Male 2018 746
TX_CURR Age/Sex: 15-19 Female 2018 19
TX_CURR Age/Sex: 15-19 Female 2018 1,090
TX_CURR Age/Sex: 15-19 Male 2018 101
TX_CURR Age/Sex: 15-19 Male 2018 644
TX_CURR Age/Sex: 20-24 Female 2018 36
TX_CURR Age/Sex: 20-24 Female 2018 2,176
TX_CURR Age/Sex: 20-24 Male 2018 129
TX_CURR Age/Sex: 20-24 Male 2018 1,027
TX_CURR Age/Sex: 25-49 Female 2018 141
TX_CURR Age/Sex: 25-49 Female 2018 21,392
TX_CURR Age/Sex: 25-49 Male 2018 687
TX_CURR Age/Sex: 25-49 Male 2018 12,410
TX_CURR Age/Sex: 50+ Female 2018 14
TX_CURR Age/Sex: 50+ Female 2018 4,401
TX_CURR Age/Sex: 50+ Male 2018 334
TX_CURR Age/Sex: 50+ Male 2018 4,056
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 1,726
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 50,405
TX_CURR Sum of age/sex disaggregates 2018 1,734
TX_CURR Sum of Age/Sex disaggregations 2018 120
TX_NEW By Age/Sex: <1 2018 20
TX_NEW By Age/Sex: <1 2018 85
TX_NEW By Age/Sex: 1-9 2018 63
TX_NEW By Age/Sex: 1-9 2018 196
TX_NEW By Age/Sex: 10-14 Female 2018 1
TX_NEW By Age/Sex: 10-14 Female 2018 80
TX_NEW By Age/Sex: 10-14 Male 2018 107
TX_NEW By Age/Sex: 10-14 Male 2018 199
TX_NEW By Age/Sex: 15-19 Female 2018 10
TX_NEW By Age/Sex: 15-19 Female 2018 379
TX_NEW By Age/Sex: 15-19 Male 2018 72
TX_NEW By Age/Sex: 15-19 Male 2018 244
TX_NEW By Age/Sex: 20-24 Female 2018 1
TX_NEW By Age/Sex: 20-24 Female 2018 92
TX_NEW By Age/Sex: 20-24 Male 2018 92
TX_NEW By Age/Sex: 20-24 Male 2018 681
TX_NEW By Age/Sex: 25-49 Female 2018 22
TX_NEW By Age/Sex: 25-49 Female 2018 1,263
TX_NEW By Age/Sex: 25-49 Male 2018 482
TX_NEW By Age/Sex: 25-49 Male 2018 3,173
TX_NEW By Age/Sex: 50+ Female 2018 10
TX_NEW By Age/Sex: 50+ Female 2018 842
TX_NEW By Age/Sex: 50+ Male 2018 238
TX_NEW By Age/Sex: 50+ Male 2018 1,335
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 1,118
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 8,569
TX_NEW Sum of Age/Sex disaggregates 2018 1,035
TX_NEW Sum of Age/Sex disaggregates 2018 8,288
TX_PVLS <15, Undocumented Test Indication, Female 2018 2
TX_PVLS <15, Undocumented Test Indication, Female 2018 2
TX_PVLS <15, Undocumented Test Indication, Female 2018 67
TX_PVLS <15, Undocumented Test Indication, Female 2018 80
TX_PVLS <15, Undocumented Test Indication, Male 2018 1
TX_PVLS <15, Undocumented Test Indication, Male 2018 1
TX_PVLS <15, Undocumented Test Indication, Male 2018 45
TX_PVLS <15, Undocumented Test Indication, Male 2018 48
TX_PVLS 15+, Undocumented Test Indication, Female 2018 30
TX_PVLS 15+, Undocumented Test Indication, Female 2018 33
TX_PVLS 15+, Undocumented Test Indication, Female 2018 1,136
TX_PVLS 15+, Undocumented Test Indication, Female 2018 1,246
TX_PVLS 15+, Undocumented Test Indication, Male 2018 20
TX_PVLS 15+, Undocumented Test Indication, Male 2018 22
TX_PVLS 15+, Undocumented Test Indication, Male 2018 758
TX_PVLS 15+, Undocumented Test Indication, Male 2018 831
TX_PVLS Breastfeeding, Undocumented Test Indication 2018 1
TX_PVLS Breastfeeding, Undocumented Test Indication 2018 1
TX_PVLS Breastfeeding, Undocumented Test Indication 2018 57
TX_PVLS Breastfeeding, Undocumented Test Indication 2018 61
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 1,172
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 44,101
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 1,066
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 40,094
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 35
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,299
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 2
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 67
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 23
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 865
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 1
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 45
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 541
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 20,347
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 30
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 1,136
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 361
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 13,571
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 20
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 758
TX_PVLS Numerator: Indication: Routine 2018 960
TX_PVLS Numerator: Indication: Routine 2018 36,082
TX_PVLS Numerator: Indication: Targeted 2018 53
TX_PVLS Numerator: Indication: Targeted 2018 2,006
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 29
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 1,090
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Targeted 2018 1
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Targeted 2018 57
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 57
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 2,172
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Targeted 2018 3
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Targeted 2018 120
TX_PVLS Pregnant, Undocumented Test Indication 2018 3
TX_PVLS Pregnant, Undocumented Test Indication 2018 4
TX_PVLS Pregnant, Undocumented Test Indication 2018 120
TX_PVLS Pregnant, Undocumented Test Indication 2018 136
TX_PVLS Undocumented Test Indication 2018 53
TX_PVLS Undocumented Test Indication 2018 58
TX_PVLS Undocumented Test Indication 2018 2,006
TX_PVLS Undocumented Test Indication 2018 2,205
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 38
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,430
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 2
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 80
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 25
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 954
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 1
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 48
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 596
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 22,383
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 33
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 1,247
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 397
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 14,923
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 22
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 831
TX_PVLS_den Denominator: Indication: Routine 2018 1,056
TX_PVLS_den Denominator: Indication: Routine 2018 39,690
TX_PVLS_den Denominator: Indication: Targeted 2018 58
TX_PVLS_den Denominator: Indication: Targeted 2018 2,206
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 31
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 1,192
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Targeted 2018 1
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Targeted 2018 61
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 64
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 2,382
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Targeted 2018 4
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Targeted 2018 136
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 2
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 279
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 46
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 290
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 166
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 5,711
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 342
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 2,545
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 556
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 8,825
TX_RET Numerator by Status: Breastfeeding 2018 1
TX_RET Numerator by Status: Breastfeeding 2018 25
TX_RET Numerator by Status: Pregnant 2018 14
TX_RET Numerator by Status: Pregnant 2018 447
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 615
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 9,687
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 297
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 50
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 310
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 183
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 6,298
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 380
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2,782
TX_RET_den Denominator by Status: Breastfeeding 2018 1
TX_RET_den Denominator by Status: Breastfeeding 2018 27
TX_RET_den Denominator by Status: Pregnant 2018 17
TX_RET_den Denominator by Status: Pregnant 2018 555
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 1,201
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 45,401
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 1,191
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 43
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 44
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 619
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 485
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 3
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 1,451
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 159
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 1,375
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2018 190
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2018 849
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 26,198
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 16,377
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 32
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 1,218
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 4
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 136
TX_TB_den Denominator: By Screen Result: Negative 2018 1,165
TX_TB_den Denominator: By Screen Result: Negative 2018 44,039
TX_TB_den Denominator: By Screen Result: Positive 2018 36
TX_TB_den Denominator: By Screen Result: Positive 2018 1,362
TX_TB_den Denominator: By Specimen Sent: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 36
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 1,362
Cross Cutting Budget Categories and Known Amounts Total: $138,736
Water $45,000
Post GBV Care
Gender: Gender Based Violence (GBV) $93,736